This Generac Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Is it the Right Time to Add Phibro Stock to Your Portfolio?

Phibro Animal Health (PAHC) is gaining momentum from strong Animal Health segment growth, driven by the Zoetis MFA acquisition, vaccine expansion, and mineral nutrition demand recovery. However, the company faces headwinds from macroeconomic risks, trade policy uncertainties, and foreign exchange volatility that continue to pressure reported results.

Eli Lilly To Rally Over 21%? Here Are 10 Top Analyst Forecasts For Thursday

Analysts raised targets for Everpure, Eli Lilly and Delek US, while cutting targets for Constellation, Tyler, ArriVent and Netflix.

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Analysts initiated coverage: Neutral on Honeywell Aerospace; Outperform on M&T Bank and SailPoint; Buy on Ambiq Micro; Overweight on Abbott.

Shares of semiconductor and chip-related companies are trading lower after reports suggesting that OpenAI's annualized revenue is approximately $20 billion less than previously indicated, which may weaken demand and pricing sentiment in sectors exposed to compute buildout.

Stifel Initiates Coverage On Entegris with Buy Rating, Announces Price Target of $200

Stifel analyst Brian Chin initiates coverage on Entegris (NASDAQ:ENTG) with a Buy rating and announces Price Target of $200.

Shares of semiconductor and chip companies are trading higher amid broader technology sector gains after Broadcom's plans to finance up to $60 billion to provide chips for Anthropic. Also, reports suggesting Samsung may raise HBM prices threefold in 2027 underpins demand and pricing power confidence across the sector.